These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 12898533)

  • 1. Astrocyte-targeted expression of interleukin-6 protects the central nervous system during neuroglial degeneration induced by 6-aminonicotinamide.
    Penkowa M; Camats J; Hadberg H; Quintana A; Rojas S; Giralt M; Molinero A; Campbell IL; Hidalgo J
    J Neurosci Res; 2003 Aug; 73(4):481-96. PubMed ID: 12898533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metallothionein prevents neurodegeneration and central nervous system cell death after treatment with gliotoxin 6-aminonicotinamide.
    Penkowa M; Quintana A; Carrasco J; Giralt M; Molinero A; Hidalgo J
    J Neurosci Res; 2004 Jul; 77(1):35-53. PubMed ID: 15197737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-6 deficiency leads to reduced metallothionein-I+II expression and increased oxidative stress in the brain stem after 6-aminonicotinamide treatment.
    Penkowa M; Hidalgo J
    Exp Neurol; 2000 May; 163(1):72-84. PubMed ID: 10785446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metallothionein-I overexpression alters brain inflammation and stimulates brain repair in transgenic mice with astrocyte-targeted interleukin-6 expression.
    Penkowa M; Camats J; Giralt M; Molinero A; Hernández J; Carrasco J; Campbell IL; Hidalgo J
    Glia; 2003 May; 42(3):287-306. PubMed ID: 12673834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astrocyte-targeted expression of interleukin-3 and interferon-alpha causes region-specific changes in metallothionein expression in the brain.
    Giralt M; Carrasco J; Penkowa M; Morcillo MA; Santamaría J; Campbell IL; Hidalgo J
    Exp Neurol; 2001 Apr; 168(2):334-46. PubMed ID: 11259121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metallothioneins are upregulated in symptomatic mice with astrocyte-targeted expression of tumor necrosis factor-alpha.
    Carrasco J; Giralt M; Penkowa M; Stalder AK; Campbell IL; Hidalgo J
    Exp Neurol; 2000 May; 163(1):46-54. PubMed ID: 10785443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metallothionein-1+2 deficiency increases brain pathology in transgenic mice with astrocyte-targeted expression of interleukin 6.
    Giralt M; Penkowa M; Hernández J; Molinero A; Carrasco J; Lago N; Camats J; Campbell IL; Hidalgo J
    Neurobiol Dis; 2002 Apr; 9(3):319-38. PubMed ID: 11950277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered central nervous system cytokine-growth factor expression profiles and angiogenesis in metallothionein-I+II deficient mice.
    Penkowa M; Carrasco J; Giralt M; Molinero A; Hernández J; Campbell IL; Hidalgo J
    J Cereb Blood Flow Metab; 2000 Aug; 20(8):1174-89. PubMed ID: 10950378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired inflammatory response to glial cell death in genetically metallothionein-I- and -II-deficient mice.
    Penkowa M; Giralt M; Moos T; Thomsen PS; Hernández J; Hidalgo J
    Exp Neurol; 1999 Mar; 156(1):149-64. PubMed ID: 10192786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of metallothionein-I and -III expression in the CNS of transgenic mice with astrocyte-targeted expression of interleukin 6.
    Carrasco J; Hernandez J; Gonzalez B; Campbell IL; Hidalgo J
    Exp Neurol; 1998 Oct; 153(2):184-94. PubMed ID: 9784278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profound increase in sensitivity to glutamatergic- but not cholinergic agonist-induced seizures in transgenic mice with astrocyte production of IL-6.
    Samland H; Huitron-Resendiz S; Masliah E; Criado J; Henriksen SJ; Campbell IL
    J Neurosci Res; 2003 Jul; 73(2):176-87. PubMed ID: 12836160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metallothionein 1+2 protect the CNS during neuroglial degeneration induced by 6-aminonicotinamide.
    Penkowa M; Giralt M; Camats J; Hidalgo J
    J Comp Neurol; 2002 Mar; 444(2):174-89. PubMed ID: 11835189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strongly compromised inflammatory response to brain injury in interleukin-6-deficient mice.
    Penkowa M; Moos T; Carrasco J; Hadberg H; Molinero A; Bluethmann H; Hidalgo J
    Glia; 1999 Feb; 25(4):343-57. PubMed ID: 10028917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metallothionein reduces central nervous system inflammation, neurodegeneration, and cell death following kainic acid-induced epileptic seizures.
    Penkowa M; Florit S; Giralt M; Quintana A; Molinero A; Carrasco J; Hidalgo J
    J Neurosci Res; 2005 Feb; 79(4):522-34. PubMed ID: 15614785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metallothionein-1+2 protect the CNS after a focal brain injury.
    Giralt M; Penkowa M; Lago N; Molinero A; Hidalgo J
    Exp Neurol; 2002 Jan; 173(1):114-28. PubMed ID: 11771944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M-CSF deficiency leads to reduced metallothioneins I and II expression and increased tissue damage in the brain stem after 6-aminonicotinamide treatment.
    Penkowa M; Poulsen C; Carrasco J; Hidalgo J
    Exp Neurol; 2002 Aug; 176(2):308-21. PubMed ID: 12359172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metallothionein treatment reduces proinflammatory cytokines IL-6 and TNF-alpha and apoptotic cell death during experimental autoimmune encephalomyelitis (EAE).
    Penkowa M; Hidalgo J
    Exp Neurol; 2001 Jul; 170(1):1-14. PubMed ID: 11421579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic GMP phosphodiesterase inhibition alters the glial inflammatory response, reduces oxidative stress and cell death and increases angiogenesis following focal brain injury.
    Pifarré P; Prado J; Giralt M; Molinero A; Hidalgo J; Garcia A
    J Neurochem; 2010 Feb; 112(3):807-17. PubMed ID: 20002517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glial fibrillary acidic protein gene promoter is differently modulated by transforming growth factor-beta 1 in astrocytes from distinct brain regions.
    Sousa Vde O; Romão L; Neto VM; Gomes FC
    Eur J Neurosci; 2004 Apr; 19(7):1721-30. PubMed ID: 15078546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astrocyte-specific overexpression of insulin-like growth factor-I promotes brain overgrowth and glial fibrillary acidic protein expression.
    Ye P; Popken GJ; Kemper A; McCarthy K; Popko B; D'Ercole AJ
    J Neurosci Res; 2004 Nov; 78(4):472-84. PubMed ID: 15468174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.